0000950170-24-067666.txt : 20240603 0000950170-24-067666.hdr.sgml : 20240603 20240603083442 ACCESSION NUMBER: 0000950170-24-067666 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240531 FILED AS OF DATE: 20240603 DATE AS OF CHANGE: 20240603 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shukla Sanjay CENTRAL INDEX KEY: 0001671026 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37378 FILM NUMBER: 241012095 MAIL ADDRESS: STREET 1: C/O ATYR PHARMA, INC. STREET 2: 10240 SORRENTO VALLEY ROAD, SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: aTYR PHARMA INC CENTRAL INDEX KEY: 0001339970 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 203435077 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10240 SORRENTO VALLEY ROAD STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8587318389 MAIL ADDRESS: STREET 1: 10240 SORRENTO VALLEY ROAD STREET 2: SUITE 300 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 ownership.xml 4 X0508 4 2024-05-31 0001339970 aTYR PHARMA INC LIFE 0001671026 Shukla Sanjay 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121 true true false false President and CEO false Common Stock 2024-05-31 4 P false 20000 1.8070 A 136548 D Represents weighted average price for the shares. The shares were purchased at prices ranging from $1.77 to $1.86 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price. /s/ Nancy E. Denyes, as Attorney-in-Fact 2024-06-03